Nuclear receptors in cell life and death

The balance between cell proliferation and programmed cell death (apoptosis) determines body patterns during animal development and controls compartment sizes, tissue architecture and remodeling. The removal of primordial structures by apoptosis allows the organism to develop sex specifically and to adapt for novel functions at later stages; apoptosis also limits the size of evolving structures. It is a ubiquitous function that is essential for all cells. Although inappropriate regulation or execution of apoptosis leads to disease, such as cancer, there is now evidence for its great therapeutic potential. This would be particularly true if apoptosis could be targeted at defined cell compartments, rather than acting ubiquitously like chemotherapy. Here, we discuss the potential of nuclear receptor ligands, many of which act through their cognate receptors in defined body compartments as modulators of cell life and death, with special emphasis on the molecular pathways by which these receptors affect cell-cycle progression, survival and apoptosis.

[1]  P. Herrlich,et al.  Transcriptional cross-talk, the second mode of steroid hormone receptor action , 1998, Journal of Molecular Medicine.

[2]  K. Korach Insights from the study of animals lacking functional estrogen receptor. , 1994, Science.

[3]  C. Fabian Breast cancer chemoprevention: beyond tamoxifen , 2001, Breast Cancer Research.

[4]  J. Dussault,et al.  Thyroid hormones and brain development. , 1987, Annual review of physiology.

[5]  J. Gustafsson,et al.  Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors. , 2001, Cancer research.

[6]  D. Bernhard,et al.  Gene expression profiles of proliferating vs. G1/G0 arrested human leukemia cells suggest a mechanism for glucocorticoid‐induced apoptosis , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[7]  P. Goss,et al.  Estrogen and the risk of breast cancer. , 2001, The New England journal of medicine.

[8]  L. Altucci,et al.  Autonomous rexinoid death signaling is suppressed by converging signaling pathways in immature leukemia cells. , 2001, Molecular endocrinology.

[9]  P. Fenaux,et al.  All-trans retinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia. , 2001, Seminars in hematology.

[10]  K. Korach,et al.  Estrogen receptor null mice: what have we learned and where will they lead us? , 1999, Endocrine reviews.

[11]  H. Gronemeyer,et al.  Therapeutic potential of selective modulators of nuclear receptor action. , 1998, Current opinion in chemical biology.

[12]  E. Thompson,et al.  Mechanisms of T-cell Apoptosis Induced by Glucocorticoids , 1999, Trends in Endocrinology & Metabolism.

[13]  P. Chambon A decade of molecular biology of retinoic acid receptors , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[14]  Elizabeth Gould,et al.  Stress and hippocampal neurogenesis , 1999, Biological Psychiatry.

[15]  T. McDonnell,et al.  Calcitriol-Induced Apoptosis in LNCaP Cells Is Blocked By Overexpression of Bcl-21. , 2000, Endocrinology.

[16]  John Calvin Reed,et al.  Apoptosis in Xenopus tadpole tail muscles involves Bax‐dependent pathways , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  M. Sporn,et al.  Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer. , 1999, Journal of the National Cancer Institute.

[18]  L. Andersson,et al.  A role for estrogen receptor β in the regulation of growth of the ventral prostate , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[19]  R. Weinberg,et al.  AIB1 enhances estrogen-dependent induction of cyclin D1 expression. , 2001, Cancer research.

[20]  J. Isaacs,et al.  Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancer , 1996, The Prostate.

[21]  P. Chambon,et al.  Essential roles of retinoic acid signaling in interdigital apoptosis and control of BMP-7 expression in mouse autopods. , 1999, Developmental biology.

[22]  J. Bernal Thyroid hormones and brain development. , 1995, Vitamins and hormones.

[23]  A. Robles,et al.  Expression of G1 cyclins, cyclin-dependent kinases, and cyclin-dependent kinase inhibitors in androgen-induced prostate proliferation in castrated rats. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[24]  Y. Geng,et al.  Specific protection against breast cancers by cyclin D1 ablation , 2001, Nature.

[25]  M. Merino,et al.  Phase I clinical trial of alitretinoin and tamoxifen in breast cancer patients: toxicity, pharmacokinetic, and biomarker evaluations. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  R. Buckle,et al.  Ligand-independent recruitment of steroid receptor coactivators to estrogen receptor by cyclin D1. , 1998, Genes & development.

[27]  L. Altucci,et al.  17beta-Estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G(1)-arrested human breast cancer cells. , 1996, Oncogene.

[28]  A. Suzuki,et al.  Down regulation of Bcl-2 is the first step on Fas-mediated apoptosis of male reproductive tract. , 1996, Oncogene.

[29]  S. Cowley,et al.  Estrogen Receptors α and β Form Heterodimers on DNA* , 1997, The Journal of Biological Chemistry.

[30]  H. Gronemeyer,et al.  Transcription factors 3: nuclear receptors. , 1995, Protein profile.

[31]  Mutations at the boundary of the hinge and ligand binding domain of the androgen receptor confer increased transactivation function. , 2001, Molecular endocrinology.

[32]  M. Tsai,et al.  Regulation of androgen-dependent prostatic cancer cell growth: androgen regulation of CDK2, CDK4, and CKI p16 genes. , 1997, Cancer research.

[33]  A. Iavarone,et al.  Induced differentiation of U937 cells by 1,25-dihydroxyvitamin D3 involves cell cycle arrest in G1 that is preceded by a transient proliferative burst and an increase in cyclin expression. , 1999, Blood.

[34]  J. Gustafsson,et al.  Mouse estrogen receptor beta forms estrogen response element-binding heterodimers with estrogen receptor alpha. , 1997, Molecular endocrinology.

[35]  S. Lippman,et al.  Mediation of N-(4-hydoxyphenyl)retinamide-induced apoptosis in human cancer cells by different mechanisms. , 1999, Cancer research.

[36]  G. Buchanan,et al.  Mutations in the androgen receptor gene are associated with progression of human prostate cancer to androgen independence. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[37]  U. Veronesi,et al.  Retinoids in cancer chemoprevention. Clinical trials with the synthetic analogue fenretinide. , 1995, Annals of the New York Academy of Sciences.

[38]  P. Hershberger,et al.  1,25-Dihydroxycholecalciferol (1,25-D3) inhibits the growth of squamous cell carcinoma and down-modulates p21(Waf1/Cip1) in vitro and in vivo. , 1999, Cancer research.

[39]  R. Evans,et al.  The RXR heterodimers and orphan receptors , 1995, Cell.

[40]  C. Powers,et al.  Ribozyme Targeting Demonstrates That the Nuclear Receptor Coactivator AIB1 Is a Rate-limiting Factor for Estrogen-dependent Growth of Human MCF-7 Breast Cancer Cells* , 2001, The Journal of Biological Chemistry.

[41]  R A Irvine,et al.  Breast cancer susceptibility gene 1 (BRCAI) is a coactivator of the androgen receptor. , 2000, Cancer research.

[42]  L. Gerschenson,et al.  Hormonal regulation of cell death in rabbit uterine epithelium. , 1987, The American journal of pathology.

[43]  R. Bernards,et al.  CDK-Independent Activation of Estrogen Receptor by Cyclin D1 , 1997, Cell.

[44]  P. Chambon,et al.  Embryonic retinoic acid synthesis is essential for early mouse post-implantation development , 1999, Nature Genetics.

[45]  B. McEwen,et al.  Controversies surrounding glucocorticoid-mediated cell death in the hippocampus , 1997, Journal of Chemical Neuroanatomy.

[46]  S. Pilkis,et al.  Rat liver 6‐phosphofructo 2‐kinase/ fructose 2,6‐bisphosphatase: A review of relationships between the two activities of the enzyme , 1984, Journal of cellular biochemistry.

[47]  S. Tabibzadeh The signals and molecular pathways involved in human menstruation, a unique process of tissue destruction and remodelling. , 1996, Molecular human reproduction.

[48]  J. Mester,et al.  Estrogen induction of the cyclin D1 promoter: involvement of a cAMP response-like element. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[49]  J. Graham,et al.  Physiological action of progesterone in target tissues. , 1997, Endocrine reviews.

[50]  S. Elledge,et al.  Cyclin D1 provides a link between development and oncogenesis in the retina and breast , 1995, Cell.

[51]  J. Gustafsson,et al.  Cloning of a novel receptor expressed in rat prostate and ovary. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[52]  E. Perez,et al.  Breast cancer prevention trials , 2000, Current oncology reports.

[53]  R. Sutherland,et al.  Mechanisms of Cyclin-Dependent Kinase Inactivation by Progestins , 1998, Molecular and Cellular Biology.

[54]  A. Iavarone,et al.  Transcriptional activation of the human p21(WAF1/CIP1) gene by retinoic acid receptor. Correlation with retinoid induction of U937 cell differentiation. , 1996, The Journal of biological chemistry.

[55]  Emma Lees,et al.  Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice , 1994, Nature.

[56]  G. Shyamala,et al.  Essential role of endogenous estrogen in directly stimulating mammary growth demonstrated by implants containing pure antiestrogens. , 1994, Endocrinology.

[57]  橋本 貢士 An unliganded thyroid hormone receptor causes severe neurological dysfunction , 2002 .

[58]  J. Welsh Induction of apoptosis in breast cancer cells in response to vitamin D and antiestrogens. , 1994, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[59]  M. Jäättelä,et al.  Apoptosis induced by vitamin D compounds in breast cancer cells is inhibited by Bcl-2 but does not involve known caspases or p53. , 1999, Cancer research.

[60]  C. Carlberg,et al.  Differential apoptotic response of human melanoma cells to 1α,25-dihydroxyvitamin D3 and its analogues , 1998, Cell Death and Differentiation.

[61]  G. Bubley,et al.  Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer. , 1995, The New England journal of medicine.

[62]  L J Peters,et al.  Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. , 1990, The New England journal of medicine.

[63]  S. Haslam,et al.  Role of epidermal growth factor in the acquisition of ovarian steroid hormone responsiveness in the normal mouse mammary gland , 1998, Journal of cellular physiology.

[64]  R. Sutherland,et al.  Antiprogestin inhibition of cell cycle progression in T-47D breast cancer cells is accompanied by induction of the cyclin-dependent kinase inhibitor p21. , 1997, Molecular endocrinology.

[65]  L. Altucci,et al.  RAR‐independent RXR signaling induces t(15;17) leukemia cell maturation , 1999, The EMBO journal.

[66]  K. Kaestner,et al.  DNA Binding of the Glucocorticoid Receptor Is Not Essential for Survival , 1998, Cell.

[67]  W. Liu,et al.  Glucocorticoid-induced cell death requires autoinduction of glucocorticoid receptor expression in human leukemic T cells. , 1999, Cancer research.

[68]  L. Salamonsen Current Concepts of the Mechanisms of Menstruation: A Normal Process of Tissue Destruction , 1998, Trends in Endocrinology & Metabolism.

[69]  C. Haslett,et al.  Pharmacological manipulation of granulocyte apoptosis: potential therapeutic targets. , 1999, Trends in pharmacological sciences.

[70]  A. Lupulescu Estrogen use and cancer incidence: a review. , 1995, Cancer investigation.

[71]  T. Bäckström,et al.  Apoptosis, proliferation, and sex hormone receptors in superficial parts of human endometrium at the end of the secretory phase. , 1999, The Journal of clinical endocrinology and metabolism.

[72]  M. Beato,et al.  Progestins Prevent Apoptosis in a Rat Endometrial Cell Line and Increase the Ratio of bcl-X L tobcl-X S * , 1997, The Journal of Biological Chemistry.

[73]  J. Gustafsson,et al.  Generation and reproductive phenotypes of mice lacking estrogen receptor beta. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[74]  K. Korach,et al.  Physiological coupling of growth factor and steroid receptor signaling pathways: estrogen receptor knockout mice lack estrogen-like response to epidermal growth factor. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[75]  J. Welsh,et al.  Apoptotic regression of MCF-7 xenografts in nude mice treated with the vitamin D3 analog, EB1089. , 1998, Endocrinology.

[76]  R. Gallagher,et al.  The molecular biology of acute promyelocytic leukemia. , 1999, Cancer treatment and research.

[77]  Philippe Kastner,et al.  Nonsteroid nuclear receptors: What Are genetic studies telling us about their role in real life? , 1995, Cell.

[78]  S. Minucci,et al.  Retinoid receptors in health and disease: co-regulators and the chromatin connection. , 1999, Seminars in cell & developmental biology.

[79]  Betty H. Johnson,et al.  Glucocorticoids, oxysterols, and cAMP with glucocorticoids each cause apoptosis of CEM cells and suppress c-myc , 1999, The Journal of Steroid Biochemistry and Molecular Biology.

[80]  K. Korach,et al.  Stromal estrogen receptors mediate mitogenic effects of estradiol on uterine epithelium. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[81]  P. Fenaux,et al.  Differentiation therapy for acute promyelocytic leukemia. , 1997, The New England journal of medicine.

[82]  O. Jänne,et al.  Cyclin D1 binds the androgen receptor and regulates hormone-dependent signaling in a p300/CBP-associated factor (P/CAF)-dependent manner. , 2001, Molecular endocrinology.

[83]  G. Stamp,et al.  Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. , 1995, Genes & development.

[84]  S. J. Higgins,et al.  The endocrinology and developmental biology of the prostate. , 1987, Endocrine reviews.

[85]  C. Paraskeva,et al.  Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy. , 2000, Cancer research.

[86]  K. Burnstein,et al.  Antiproliferative Effect of 1α,25-Dihydroxyvitamin D3 in Human Prostate Cancer Cell Line LNCaP Involves Reduction of Cyclin-Dependent Kinase 2 Activity and Persistent G1 Accumulation. , 1998, Endocrinology.

[87]  M. Sporn,et al.  Role of retinoids in differentiation and carcinogenesis. , 1983, Cancer research.

[88]  K. Miyazono,et al.  Convergence of transforming growth factor-beta and vitamin D signaling pathways on SMAD transcriptional coactivators. , 1999, Science.

[89]  W. Hong,et al.  Augmentation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by the synthetic retinoid 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) through up-regulation of TRAIL receptors in human lung cancer cells. , 2000, Cancer research.

[90]  L. Wakefield,et al.  Transforming growth factors-β are not good biomarkers of chemopreventive efficacy in a preclinical breast cancer model system , 2000, Breast Cancer Research.

[91]  M. J. van de Vijver,et al.  Cyclin D1 gene amplification and overexpression are present in ductal carcinoma in situ of the breast , 1999, The Journal of pathology.

[92]  J. Swinnen,et al.  E2F activity is biphasically regulated by androgens in LNCaP cells. , 2001, Biochemical and biophysical research communications.

[93]  B. O’Malley,et al.  Reproductive phenotypes of the progesterone receptor null mutant mouse , 1996, The Journal of Steroid Biochemistry and Molecular Biology.

[94]  P. Chambon,et al.  RAR‐specific agonist/antagonists which dissociate transactivation and AP1 transrepression inhibit anchorage‐independent cell proliferation. , 1995, The EMBO journal.

[95]  L. Altucci,et al.  Retinoic acid-induced apoptosis in leukemia cells is mediated by paracrine action of tumor-selective death ligand TRAIL , 2001, Nature Medicine.

[96]  John Calvin Reed,et al.  Differential expression of members of the bcl-2 gene family in proliferative and secretory human endometrium: glandular epithelial cell apoptosis is associated with increased expression of bax. , 1997, The Journal of clinical endocrinology and metabolism.

[97]  Estrogen induces early and timed activation of cyclin-dependent kinases 4, 5, and 6 and increases cyclin messenger ribonucleic acid expression in rat uterus. , 1997, Endocrinology.

[98]  F. Tronche,et al.  New insights into glucocorticoid and mineralocorticoid signaling: lessons from gene targeting. , 2000, Advances in pharmacology.

[99]  R. Bouillon,et al.  Two novel 14-Epi-analogues of 1,25-dihydroxyvitamin D3 inhibit the growth of human breast cancer cells in vitro and in vivo. , 2000, Cancer research.

[100]  R. Lotan,et al.  Implication of multiple mechanisms in apoptosis induced by the synthetic retinoid CD437 in human prostate carcinoma cells , 2000, Oncogene.

[101]  A. Bilancio,et al.  Steroid‐induced androgen receptor–oestradiol receptor β–Src complex triggers prostate cancer cell proliferation , 2000, The EMBO journal.

[102]  J. Ashwell,et al.  Glucocorticoids in T cell development and function*. , 2000, Annual review of immunology.

[103]  W. Hong,et al.  13-cis-retinoic acid in the treatment of oral leukoplakia. , 1986, The New England journal of medicine.

[104]  L. Freedman,et al.  Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. , 1996, Genes & development.

[105]  M. Merino,et al.  Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions , 1995, Nature Medicine.

[106]  J. Eisman,et al.  Cross-talk between 1,25-Dihydroxyvitamin D3 and Transforming Growth Factor-β Signaling Requires Binding of VDR and Smad3 Proteins to Their Cognate DNA Recognition Elements* , 2001, The Journal of Biological Chemistry.

[107]  M. Sporn New Agents for Chemoprevention of Prostate Cancer , 1999, European Urology.

[108]  R. Lotan,et al.  Inhibition of tumor cell growth by retinoids. , 1990, Methods in enzymology.

[109]  H. Adami,et al.  Low-potency oestrogen and risk of endometrial cancer: a case-control study , 1999, The Lancet.

[110]  M. Sherman Theories of Endometrial Carcinogenesis: A Multidisciplinary Approach , 2000, Modern Pathology.

[111]  T. Mcguire,et al.  Vitamin D(3)-induced apoptosis of murine squamous cell carcinoma cells. Selective induction of caspase-dependent MEK cleavage and up-regulation of MEKK-1. , 2001, The Journal of biological chemistry.